BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20934205)

  • 1. Status of tumor markers in epithelial ovarian cancer has there been any progress? A review.
    Husseinzadeh N
    Gynecol Oncol; 2011 Jan; 120(1):152-7. PubMed ID: 20934205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
    Jurisicova A; Jurisica I; Kislinger T
    Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics and biomarkers for ovarian cancer diagnosis.
    Zhang B; Barekati Z; Kohler C; Radpour R; Asadollahi R; Holzgreve W; Zhong XY
    Ann Clin Lab Sci; 2010; 40(3):218-25. PubMed ID: 20689132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of proteomics in ovarian cancer: which sample should be used?
    Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
    Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer: biomarker proteomic diagnosis in progress.
    Zhang Y; Guo B; Bi R
    Appl Biochem Biotechnol; 2012 Oct; 168(4):910-6. PubMed ID: 22945560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of biomarkers for the ovarian cancer diagnosis.
    Zhang B; Cai FF; Zhong XY
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):119-23. PubMed ID: 21632171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?].
    Petri AL; Høgdall E; Engelholm SA; Christensen IJ; Kjaer SK; Høgdall CK
    Ugeskr Laeger; 2007 Aug; 169(33):2614-9. PubMed ID: 17725906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of biological markers in the diagnosis and monitoring of cystadenocarcinoma].
    Bidart JM; Bellet D
    Rev Prat; 1989 Nov; 39(26):2317-20. PubMed ID: 2595221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current situation and prospect of proteomics research in ovarian malignancies].
    Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):577-8. PubMed ID: 17181963
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular predictors of response and outcome in ovarian cancer.
    Canevari S; Gariboldi M; Reid JF; Bongarzone I; Pierotti MA
    Crit Rev Oncol Hematol; 2006 Oct; 60(1):19-37. PubMed ID: 16829123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers.
    Williams TI; Toups KL; Saggese DA; Kalli KR; Cliby WA; Muddiman DC
    J Proteome Res; 2007 Aug; 6(8):2936-62. PubMed ID: 17583933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker discovery in epithelial ovarian cancer by genomic approaches.
    Mok SC; Elias KM; Wong KK; Ho K; Bonome T; Birrer MJ
    Adv Cancer Res; 2007; 96():1-22. PubMed ID: 17161674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.
    Jones MB; Krutzsch H; Shu H; Zhao Y; Liotta LA; Kohn EC; Petricoin EF
    Proteomics; 2002 Jan; 2(1):76-84. PubMed ID: 11788994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CA 125 in epithelial ovarian cancer].
    Mogensen O
    Ugeskr Laeger; 1998 May; 160(22):3236. PubMed ID: 9621807
    [No Abstract]   [Full Text] [Related]  

  • 15. Data mining techniques for cancer detection using serum proteomic profiling.
    Li L; Tang H; Wu Z; Gong J; Gruidl M; Zou J; Tockman M; Clark RA
    Artif Intell Med; 2004 Oct; 32(2):71-83. PubMed ID: 15364092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New technology of diagnosis of ovarian cancer].
    Terashima Y
    Gan No Rinsho; 1988 Aug; 34(10):1427-31. PubMed ID: 2845169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.
    Gunawardana CG; Kuk C; Smith CR; Batruch I; Soosaipillai A; Diamandis EP
    J Proteome Res; 2009 Oct; 8(10):4705-13. PubMed ID: 19663500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteins' promise--progress and challenges in ovarian cancer proteomics.
    Koehn H; Oehler MK
    Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic identification of overexpressed PRDX 1 and its clinical implications in ovarian carcinoma.
    Chung KH; Lee DH; Kim Y; Kim TH; Huh JH; Chung SG; Lee S; Lee C; Ko JJ; An HJ
    J Proteome Res; 2010 Jan; 9(1):451-7. PubMed ID: 19902980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in biomarker discovery for diagnostic testing in epithelial ovarian cancer.
    Gogoi R; Srinivasan S; Fishman DA
    Expert Rev Mol Diagn; 2006 Jul; 6(4):627-37. PubMed ID: 16824035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.